TRABER PETER G Insider Trading
Get the latest insider transactions of TRABER PETER G. TRABER PETER G is Director in Caladrius Biosciences, Inc. ($NBS) and Director in TANOX INC ($TNOX) and President & CEO in GALECTIN THERAPEUTICS INC ($GALT) and Chief Medical Officer in SELECTA BIOSCIENCES INC ($SELB). Discover the current value of TRABER PETER G shares.
Address: 430 THAMER LANE HOUSTON 77025TX
TRABER PETER G is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
TNOX | TANOX INC | Director | 0 | 0.00 |
GALT | GALECTIN THERAPEUTICS INC | President & CEO | 207,333 | 263,312.91 |
NBS | CALADRIUS BIOSCIENCES, INC. | Director | 83,760 | 188,460.00 |
SELB | SELECTA BIOSCIENCES INC | Chief Medical Officer | 135,500 | 1,873,965.00 |
Insider Trading Transactions of TRABER PETER G
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
May 27 2021 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Buy | 3.99 | 20,000 | 79,850 | 135,500 |
Mar 19 2021 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Buy | 4.53 | 10,000 | 45,295 | 88,000 |
Mar 19 2021 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Buy | 4.50 | 10,000 | 45,000 | 98,000 |
Jan 12 2021 | NBS | CALADRIUS BIOSCIENCES, IN ... | TRABER PETER G | Director | Buy | 0.00 | 37,735 | 0 | 83,760 |
Jan 06 2021 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Buy | 0.00 | 38,000 | 0 | 78,000 |
Jan 06 2021 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Option Exercise | 2.99 | 230,000 | 687,700 | 230,000 |
Jan 06 2021 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Buy | 0.00 | 38,000 | 0 | 78,000 |
Jan 06 2021 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Option Exercise | 2.99 | 230,000 | 687,700 | 230,000 |
Dec 16 2020 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Buy | 3.24 | 40,000 | 129,424 | 40,000 |
Aug 04 2020 | SELB | SELECTA BIOSCIENCES INC | TRABER PETER G | Chief Medical Officer | Option Exercise | 2.38 | 650,000 | 1,547,000 | 650,000 |
Jan 14 2020 | NBS | CALADRIUS BIOSCIENCES, IN ... | TRABER PETER G | Director | Buy | 3.28 | 18,292 | 59,998 | 46,025 |
Jan 16 2019 | NBS | CALADRIUS BIOSCIENCES, IN ... | TRABER PETER G | Director | Buy | 4.95 | 12,121 | 59,999 | 27,733 |
Jan 10 2019 | NBS | CALADRIUS BIOSCIENCES, IN ... | TRABER PETER G | Director | Buy | 0.00 | 8,747 | 0 | 15,612 |
Jun 15 2018 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Buy | 0.87 | 100,000 | 87,000 | 207,333 |
Jun 15 2018 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Sell | 7.51 | 100,000 | 751,000 | 107,333 |
Jun 15 2018 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Option Exercise | 0.87 | 100,000 | 87,000 | 50,000 |
Jun 12 2018 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Buy | 0.87 | 70,000 | 60,900 | 177,333 |
Jun 12 2018 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Sell | 5.86 | 70,000 | 409,997 | 107,333 |
Jun 12 2018 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Option Exercise | 0.87 | 70,000 | 60,900 | 150,000 |
May 24 2018 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Option Exercise | 4.16 | 125,000 | 520,000 | 125,000 |
Jan 17 2018 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Option Exercise | 5.87 | 125,000 | 733,750 | 125,000 |
Jan 10 2018 | NBS | CALADRIUS BIOSCIENCES, IN ... | TRABER PETER G | Director | Option Exercise | 0.00 | 8,747 | 0 | 8,747 |
May 18 2017 | NBS | Caladrius Biosciences, In ... | TRABER PETER G | Director | Buy | 0.00 | 2,565 | 0 | 6,865 |
Jan 31 2017 | NBS | Caladrius Biosciences, In ... | TRABER PETER G | Director | Buy | 0.00 | 1,650 | 0 | 4,300 |
Jan 31 2017 | NBS | Caladrius Biosciences, In ... | TRABER PETER G | Director | Option Exercise | 3.54 | 2,750 | 9,735 | 2,750 |
Dec 06 2016 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Option Exercise | 0.87 | 220,000 | 191,400 | 220,000 |
Jun 23 2016 | NBS | Caladrius Biosciences, In ... | TRABER PETER G | Director | Buy | 0.00 | 7,500 | 0 | 26,500 |
Jun 23 2016 | NBS | Caladrius Biosciences, In ... | TRABER PETER G | Director | Option Exercise | 0.52 | 12,500 | 6,450 | 12,500 |
Jan 27 2016 | NBS | Caladrius Biosciences, In ... | TRABER PETER G | Director | Buy | 0.00 | 9,000 | 0 | 19,000 |
Jan 27 2016 | NBS | Caladrius Biosciences, In ... | TRABER PETER G | Director | Option Exercise | 0.63 | 15,000 | 9,450 | 15,000 |
Jan 22 2016 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Option Exercise | 1.37 | 134,000 | 183,580 | 134,000 |
Aug 12 2015 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Buy | 2.00 | 2,000 | 4,000 | 107,333 |
Jun 04 2015 | NBS | Caladrius Biosciences, In ... | TRABER PETER G | Director | Buy | 0.00 | 10,000 | 0 | 10,000 |
Jun 01 2015 | GALT | GALECTIN THERAPEUTICS INC | TRABER PETER G | President & CEO | Buy | 2.53 | 4,000 | 10,120 | 105,333 |
Jun 06 2006 | TNOX | TANOX INC | TRABER PETER G | Director | Option Exercise | 14.47 | 10,000 | 144,700 | 10,000 |
Jun 14 2005 | TNOX | TANOX INC | TRABER PETER G | Director | Option Exercise | 9.87 | 10,000 | 98,700 | 10,000 |
Mar 23 2004 | TNOX | TANOX INC | TRABER PETER G | Director | Option Exercise | 14.89 | 20,000 | 297,800 | 20,000 |
Mar 23 2004 | TNOX | TANOX INC | TRABER PETER G | Director | Option Exercise | 14.89 | 20,000 | 297,800 | 20,000 |